v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2024   775,728,034      
Beginning balance, value at Dec. 31, 2024 $ 60,969 $ 3,059 $ 539,642 $ (18,849) $ (462,883)
Net loss (12,887)       (12,887)
Foreign currency translation adjustments 3,559     3,559  
Share-based compensation 2,278   2,278    
Delivery of shares on vesting of restricted stock units, shares   718,350      
Delivery of shares on vesting of restricted stock units, value   $ 3 (3)    
Conversion of convertible loan notes, shares   17,105,450      
Conversion of convertible loan notes 5,740 $ 64 5,676    
Exercise of warrants shares   1,449,610      
Exercise of warrants value 487 $ 6 481    
Transfer between reserves     (3,743)   3,743
Transaction costs on issuance of shares (65)   (65)    
Ending balance, shares at Mar. 31, 2025   795,001,444      
Ending balance, value at Mar. 31, 2025 60,081 $ 3,132 544,266 (15,290) (472,027)
Beginning balance, shares at Dec. 31, 2025   795,658,504      
Beginning balance, value at Dec. 31, 2025 40,916 $ 3,135 549,622 (10,823) (501,018)
Net loss (6,719)       (6,719)
Foreign currency translation adjustments (1,748)     (1,748)  
Share-based compensation 1,605   1,605    
Delivery of shares on vesting of restricted stock units, shares   868,630      
Delivery of shares on vesting of restricted stock units, value   $ 4 (4)    
Exercise of warrants shares   1,551,695      
Exercise of warrants value   $ 6 (6)    
Transfer between reserves     (199)   199
Ending balance, shares at Mar. 31, 2026   798,078,829      
Ending balance, value at Mar. 31, 2026 $ 34,054 $ 3,145 $ 551,018 $ (12,571) $ (507,538)